Skip Global navigation and goto content

It's a New Day in Public Health.

The Florida Department of Health works to protect, promote & improve the health of all people in Florida through integrated state, county & community efforts.

Skip MegaMenu and goto content


For questions, requests and comments, contact the STD section at:

  •  850-653-2111



    Mailing Address

    Florida Department of Health Franklin County 

    139 12th St 

    Apalachicola, FL 32320 

Hepatitis B virus (HBV) is a serious health problem in the United States. Transmission of HBV from mother to infant during the perinatal period confers the greatest risk of chronic infection or death from HBV-related chronic liver disease. The Centers for Disease Control and Prevention (CDC) estimates that between 450 and 750 hepatitis B surface antigen (HBsAg) positive Florida women give birth each year; without prophylaxis, 45 to 100 infants would become infected with HBV. Ninety to 95 percent of these potential infections may be avoided through appropriate maternal screening and infant post-exposure prophylaxis.

Committed to Prevention

The Florida Perinatal Hepatitis B Prevention Program (PHBPP) is committed to the prevention of perinatal HBV infection by:

  • The Florida Department of Health in Franklin County (DOH-Franklin) partners with the PHBPP in coordinating perinatal hepatitis B prevention activities in our community.
  • Providing proactive and responsive case identification, case management, and follow-up for women, infants, and contacts locally.
  • Identifying strategies within Franklin County to promote a sustainable and efficient program that is responsive to public and ever-changing healthcare environment.

Our Objectives

Specific objectives of Florida's PHBPP are:

  • All pregnant women are tested for HBsAg.
  • HBsAg-positive women are contacted before delivery and educated about HBV infection.
  • Medical providers and delivery facilities are informed of the mothers HBsAg status.
  • Infants born to HBsAg-positive women and those of unknown status receive hepatitis B immune globulin (HBIG) and hepatitis B vaccine within 12 hours of birth, with follow-up doses of vaccine at 1 and 6 months of age.
  • Infants born to HBsAg-positive mothers receive post-vaccination testing in a timely manner to ensure protection against HBV infection.
  • A tracking system is used to ensure the infant receives appropriate post-exposure prophylaxis.
  • Household and sexual contacts of HBsAg-positive women receive pre-vaccination testing, HBIG (if necessary), and hepatitis B vaccine at recommended intervals.